Skip to main content
. 2019 Oct 9;9(1):1671763. doi: 10.1080/2162402X.2019.1671763

Figure 1.

Figure 1.

Calreticulin and NK cell activation. The exposure of calreticulin (CALR) on malignant blasts from patients with acute myeloid leukemia (AML) favors the accumulation of an activated, poly-functional population of CD11b+CD14+ myeloid cells that support natural killer (NK) cell anticancer functions. CCR7, C-C motif chemokine receptor 7, IL15RA, interleukin 15 receptor, alpha chain (IL15RA); IFN, interferon.